Madison Canning
Impact in
- Physiology top 5%
- Adenosine and Purinergic Signaling
- Otorhinolaryngology top 10%
- Head and Neck Cancer Studies
Papers in
- Oncology 5
- Cancer Immunotherapy and Biomarkers 2
- Peptidase Inhibition and Analysis 1
- Cancer Cells and Metastasis 1
-
- Cancer-related gene regulation 1
- RNA modifications and cancer 1
- Co-authors
- Miao Yu (2 shared papers)Yan Cui (2 shared papers)Michael Groves (1 shared paper)Gang Guo (1 shared paper)J. Kenneth Byrd (1 shared paper)Huidong Shi (1 shared paper)Andrew L. Mellor (1 shared paper)David H. Munn (1 shared paper)
- Journals
- Journal of Clinical Oncology (1 paper)Frontiers in Cell and Developmental Biology (1 paper)Nature Communications (1 paper)Current Treatment Options in Oncology (1 paper)Clinical Breast Cancer (1 paper)
- Partner nations
- United StatesUnited KingdomChina
In The Last Decade
Madison Canning
4 papers receiving 366 citations
Peers
Comparison fields: 5 of 51
- Physiology 60
- Otorhinolaryngology 44
- Oncology 198
- Immunology 129
- Cancer Research 89
Countries citing papers authored by Madison Canning
This map shows the geographic impact of Madison Canning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Madison Canning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Madison Canning more than expected).
Fields of papers citing papers by Madison Canning
This network shows the impact of papers produced by Madison Canning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Madison Canning. The network helps show where Madison Canning may publish in the future.
Co-authors
The 21 scholars most cited alongside Madison Canning, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 225 | |
| 2 | 2020 | 141 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 0 |
About Madison Canning
Madison Canning is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Genetics and Health, having authored 5 papers that have together received 372 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Peptidase Inhibition and Analysis (1 paper), Cancer Genomics and Diagnostics (1 paper), Breast Cancer Treatment Studies (1 paper), Cancer Cells and Metastasis (1 paper), Cancer-related gene regulation (1 paper) and RNA modifications and cancer (1 paper). The work is most often cited by research in Physiology (60 citations), Otorhinolaryngology (44 citations), Oncology (198 citations), Immunology (129 citations) and Cancer Research (89 citations). Madison Canning has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Miao Yu, Yan Cui, Michael Groves, Gang Guo, J. Kenneth Byrd, Huidong Shi, Andrew L. Mellor, David H. Munn, Bhagelu R. Achyut and Lei Huang. Their work appears in journals such as Journal of Clinical Oncology, Frontiers in Cell and Developmental Biology, Nature Communications, Current Treatment Options in Oncology and Clinical Breast Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.